膜におけるSARS-CoV-2のスパイクリフォールドの構造と抑制
Michael W Grunst1, Zhuan Qin1, Esteban Dodero-Rojas2
1Department of Microbial Pathogenesis, Yale University, New Haven, CT, USA.
まとめ
この研究は,SARS-CoV-2のエントリー中間体を視覚化して,保存されたS2ドメインを標的とした抗体が,コロナウイルスの融合を阻害する方法を明らかにしています. これらの発見は,スパイクタンパク質S2領域を標的としたパンベータコロナウイルスワクチンの開発を支持する.
科学分野:
- ウイルス学
- 構造生物学
- 免疫学
背景:
- SARS-CoV-2の侵入は,スパイクタンパク質結合 ACE2とS2ドメイン再折りによる膜融合に依存しています.
- 保存されたS2ドメインは,S1と比較してより低いシーケンスの可変性があるため,パンベータコロナウイルスワクチンのターゲットです.
研究 の 目的:
- SARS-CoV-2のスパイクタンパク質S2ドメインのウイルス-宿主膜融合時の再折り合いを視覚化します.
- S2 幹ヘリクスを標的とする抗体による抑制の仕組みを理解する.
主な方法:
- S2 リフォールディング中間物質を捕捉および分析するために,冷凍電子トモグラフィとサブトモグラフィの平均値を使用した.
- 構造データを補完するために分子動力学シミュレーションが使用されました.
主要な成果:
- S2ドメインの再折りたたむ前に,ACE2ジマーがスパイクタンパク質に交結していることが観察されました.
- S2 リフォールドの構造的中間物質は,様々な段階で捕獲されました.
- S2 幹ヘリクスを標的とするパンベータコロナウイルス中和抗体は,スパイク・プリヘアピン中間再折れを結合し,抑制することが示された.
結論:
- この研究は,S2の再折り中間物質を視覚化することによって,SARS-CoV-2の侵入過程を明らかにしています.
- パンベータコロナウイルスのS2標的抗体は,スパイクプレヘアピン中間物質を止め,S2をワクチン標的として検証することによって,感染性を中和する.
関連する概念動画
SNAREs and Membrane Fusion
10.8K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
10.8K
Mechanisms of Membrane-bending
2.6K
The living membranes are flexible due to their fluid mosaic nature; however, their bending into different shapes is an active process regulated by specific lipids and proteins. The membrane bending can be transient as seen in vesicles or stable for a long time as in microvilli. Cells regulate the size, location, and duration of the membrane curvature.
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
Membrane bending can happen due to intrinsic changes in lipid composition or extrinsic association with different proteins. The proteins involved...
2.6K
Mechanisms of Membrane Domain Formation
3.0K
Different physical properties of lipids and proteins allow them to localize and form distinct islands or domains in the membrane. Some membrane domains are formed due to protein-protein interactions, whereas others are formed due to the presence of specific lipids such as sphingolipids and sterols—for example, large proteins, such as bacteriorhodopsin, aggregate and create distinct domains.
Another mechanism for membrane domain formation involves membrane proteins interacting with...
Another mechanism for membrane domain formation involves membrane proteins interacting with...
3.0K
Membrane Fluidity
11.0K
Membrane fluidity is explained by the fluid mosaic model of the cell membrane, which describes the plasma membrane structure as a mosaic of components—including phospholipids, cholesterol, proteins, and carbohydrates—that gives the membrane a fluid character.
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
Mosaic nature of the membrane
The mosaic characteristic of the membrane helps the plasma membrane remain fluid. The integral proteins and lipids exist as separate but loosely-attached molecules in the membrane. The membrane is...
11.0K
Protein Folding Quality Check in the RER
3.7K
ER is the primary site for the maturation and folding of soluble and transmembrane secretory proteins. The calnexin cycle is a specific chaperone system that folds and assesses the confirmation of N-glycosylated proteins before they can exit the ER lumen. The primary players of this quality check pipeline are the lectins, ER-resident chaperones, and a glucosyl transferase enzyme. In case the calnexin system in the lumen fails to salvage a misfolded protein, it is transported to the cytoplasm...
3.7K
Pinching-off of Coated Vesicles
3.1K
Vesicle budding is orchestrated by distinct cytosolic proteins such as adaptor proteins, coat proteins, and GTPases. To initiate vesicle budding, membrane-bending proteins containing crescent-shaped BAR domains bind to the lipid heads in the bilayer and distort the membrane to form a protein-coated vesicle bud. Adaptors proteins such as AP2 for clathrin-coated vesicles can nucleate on the deformed membrane. Finally, coat proteins such as clathrin or COPI and COPII assemble into a coat forming...
3.1K


